↓ Skip to main content

Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two…

Overview of attention for article published in Alzheimer's Research & Therapy, May 2020
Altmetric Badge

Readers on

mendeley
109 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer’s disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study
Published in
Alzheimer's Research & Therapy, May 2020
DOI 10.1186/s13195-020-00614-5
Pubmed ID
Authors

Gerald Novak, Johannes Rolf Streffer, Maarten Timmers, David Henley, H. Robert Brashear, Jennifer Bogert, Alberto Russu, Luc Janssens, Ina Tesseur, Luc Tritsmans, Luc Van Nueten, Sebastiaan Engelborghs

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 109 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 17 16%
Student > Master 17 16%
Student > Ph. D. Student 11 10%
Researcher 10 9%
Unspecified 5 5%
Other 9 8%
Unknown 40 37%
Readers by discipline Count As %
Medicine and Dentistry 15 14%
Pharmacology, Toxicology and Pharmaceutical Science 9 8%
Biochemistry, Genetics and Molecular Biology 9 8%
Nursing and Health Professions 9 8%
Neuroscience 6 6%
Other 19 17%
Unknown 42 39%